Looking to publish in Breast Cancer Targets and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowBreast Cancer: Targets and Therapy is an international, peer reviewed, open access journal that publishes basic and translational studies as well as clinical trials on breast cancer. It encourages original and review articles on breast cancer treatment, including outcome studies incorporating preventative and integrated treatment strategies to enhance survival and quality of life for cancer patients, and covers topics including epidemiology, screening, biomarkers, metastasis, drug delivery, surgery, radiation, palliative care, health economics, and genetic and epigenetic mechanisms.
Looking to publish in Breast Cancer Targets and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Breast Cancer Targets and Therapy accepts the following article types. Click on an article type to view submission instructions.
Reviews
Invited Reviews
Original Research Papers
Meta-Analyses
Case Reports
Recent Publications
Hemodynamic Inflow-Outflow Profiling as an Integrated DCE-MRI Biomarker for Diagnosis and Risk Stratification in Breast Cancer: A Multicenter Retrospective Study
Chenyi Zhou, Yahao Guo, Zhanao Meng, Kunming Wan, Jie Qin, Yanling Wang
Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
Yang-Chuan Chen, Min-Chi Cheng, Po-Huang Chen, Chi-Hsiang Chung, Wu-Chien Chien, Ming-Shen Dai, Jia-Hong Chen, Tzu-Chuan Huang
Hsa_circ_0000520 Promotes Invasion and Metastasis of Breast Cancer Cells by Targeting HSP90AA1
Miaomiao Cai, Tao Lu, Shanmei Lv, Zhuan Zheng, Lu Gao, Huiying Wang, Xuejun Dong
A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection
Jiani Liu, Xinyu Peng, Yang Yang, Xuhui Huang, Yongtao Du, Keming Liu
The Regulatory Mechanism and Value in Early Diagnosis and Prognosis Assessment of miR-4448 in Breast Cancer
Zhenyu Zhang, Zhengrui Liu, Chao Li, Fukai Wang, Zhaokun Tian, Xiaoyu Liu, Zhiyong Yu
Frequently asked questions
How long does it take to publish?
Authors must submit proof corrections within 72 hours.
Reformat to Breast Cancer Targets and Therapy using Livewrite PremiumIs a cover letter required?
A point-by-point covering letter is required when submitting a revised manuscript after peer review.
Reformat to Breast Cancer Targets and Therapy using Livewrite PremiumWhat are the publication costs?
Invited reviews are exempt from paying any publication processing fee.
Reformat to Breast Cancer Targets and Therapy using Livewrite Premium